Dr. Chae is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 E Superior St
Suite 52261
Chicago, IL 60611Phone+1 855-826-6384
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2008 - 2011
Seoul National University College of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2024 - Present
IL State Medical License 2014 - 2026
TX State Medical License 2011 - 2014
PA State Medical License 2008 - 2011- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer.Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Kelly J Wilkinson, Emily M Whitman-Purves
Clinical Cancer Research. 2024-12-16 - First Cycle Toxicity and Survival in Patients with Rare Cancers Treated with Checkpoint Inhibitors.Megan Othus, Sandip P Patel, Young Kwang Chae, Eliana Dietrich, Howard Streicher
Journal of the National Cancer Institute. 2024-11-20 - A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Vulvar Cancers.Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel, Robert Edwards, Jennifer M Scalici
Clinical Cancer Research. 2024-11-19
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
